| Vimpat 10 mg/ml syrup EU/1/08/470/018-019 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 100 mg film-coated tablets EU/1/08/470/4-6 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 15 mg/ml syrup EU/1/08/470/14-15 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 150 mg film-coated tablets EU/1/08/470/7-9 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 200 mg film-coated tablets EU/1/08/470/10-12 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 50 mg film-coated tablets EU/1/08/470/1-3 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 50mg/ 100mg/ 150mg film-coated tablets EU/1/08/470/13 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vipdomet 12.5 mg/1000 mg film-coated tablets EU/1/13/843/013-024 |
Alogliptin (as benzoate), Metformin Hydrochloride |
Takeda Pharma A/S |
— |
| Vipdomet 12.5 mg/850 mg film-coated tablets EU/1/13/843/001-012 |
Metformin Hydrochloride, Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Vipidia 12.5 mg film-coated tablets EU/1/13/844/010-018 |
Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Vipidia 25 mg film-coated tablets EU/1/13/844/019-027 |
Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Vipidia 6.25 mg film-coated tablets EU/1/13/844/001-009 |
Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Viraferon EU/1/99/128/015 |
Interferon alfa-2b |
Schering Plough Europe |
— |
| Viramune 200 mg tablets EU/1/97/055/001 |
Nevirapine |
Boehringer Ingelheim International GmbH |
— |
| Viramune 400 mg prolonged-release tablets EU/1/97/055/007-009 |
Nevirapine |
Boehringer Ingelheim International GmbH |
— |
| Viramune 50 mg/5 mL oral suspension EU/1/97/055/002 |
Nevirapine hemihydrate |
Boehringer Ingelheim International GmbH |
— |
| Viread 123 mg film-coated tablets EU/1/01/200/004-005 |
Tenofovir disoproxil fumarate |
Gilead Sciences Ireland UC |
— |
| Viread 163 mg film-coated tablets EU/1/01/200/006-007 |
Tenofovir disoproxil fumarate |
Gilead Sciences Ireland UC |
— |
| Viread 204 mg film-coated tablets EU/1/01/200/008-009 |
Tenofovir disoproxil fumarate |
Gilead Sciences Ireland UC |
— |
| Viread 245 mg film-coated tablets EU/1/01/200/001-002 |
Tenofovir disoproxil fumarate |
Gilead Sciences Ireland UC |
— |
| Viread 33 mg/g granules EU/1/01/200/003 |
Tenofovir disoproxil fumarate |
Gilead Sciences Ireland UC |
— |
| Visudyne 15 mg powder for solution for infusion EU/1/00/140/001 |
Verteporfin |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Vitlipid N Adult concentrate for emulsion for infusion PA2059/067/001 |
Ergocalciferol, Phytomenadione, Dl-alpha-tocopherol, Retinol |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Vitlipid N Infant concentrate for emulsion for infusion PA2059/067/002 |
Ergocalciferol, Phytomenadione, Dl-alpha-tocopherol, Retinol |
Fresenius Kabi Deutschland GmbH |
Marketed |
| VITRAKVI 100 mg Capsule, hard EU/1/19/1385/002 |
LAROTRECTINIB SULFATE, LAROTRECTINIB |
Bayer AG |
— |
| VITRAKVI 20 mg/ml Oral solution EU/1/19/1385/003-004 |
LAROTRECTINIB SULFATE |
Bayer AG |
— |
| VITRAKVI 25 mg Capsule, hard EU/1/19/1385/001 |
LAROTRECTINIB, LAROTRECTINIB SULFATE |
Bayer AG |
— |
| Vivlipeg 6 mg solution for injection in pre-filled syringe EU/1/25/1967/001-002 |
Pegfilgrastim |
Biosimilar Collaborations Ireland Limited |
— |
| VIZAMYL 400 MBq/mL solution for injection EU/1/14/941/001-002 |
Flutemetamol (18F) |
GE Healthcare AS |
— |
| Vizarsin 100 mg film-coated tablets EU/1/09/551/9-12 |
Sildenafil |
KRKA, d.d., Novo mesto |
— |
| Vizarsin 100 mg orodispersible tablets EU/1/09/551/023-027 |
Sildenafil |
KRKA, d.d., Novo mesto |
— |
| Vizarsin 25 mg film-coated tablets EU/1/09/551/1-4 |
Sildenafil |
KRKA, d.d., Novo mesto |
— |
| Vizarsin 25 mg orodispersible tablets EU/1/09/551/013-017 |
Sildenafil |
KRKA, d.d., Novo mesto |
— |
| Vizarsin 50 mg film-coated tablets EU/1/09/551/5-8 |
Sildenafil |
KRKA, d.d., Novo mesto |
— |
| Vizarsin 50 mg orodispersible tablets EU/1/09/551/018-022 |
Sildenafil |
KRKA, d.d., Novo mesto |
— |
| Vizimpro 15 mg Film-coated tablet EU/1/19/1354/001 |
DACOMITINIB MONOHYDRATE |
Pfizer Europe MA EEIG |
— |
| Vizimpro 30 mg Film-coated tablet EU/1/19/1354/002 |
DACOMITINIB MONOHYDRATE |
Pfizer Europe MA EEIG |
— |
| Vizimpro 45 mg Film-coated tablet EU/1/19/1354/003 |
DACOMITINIB MONOHYDRATE |
Pfizer Europe MA EEIG |
— |
| Vocabria 30 mg film-coated tablets EU/1/20/1481/001 |
cabotegravir |
ViiV Healthcare BV |
— |
| Vocabria 400 mg prolonged-release suspension for injection EU/1/20/1481/002 |
cabotegravir |
ViiV Healthcare BV |
— |
| Vocabria 600 mg prolonged-release suspension for injection EU/1/20/1481/003 |
cabotegravir |
ViiV Healthcare BV |
— |
| Vokanamet 150 mg/1000 mg Film-coated tablet EU/1/14/918/010-012 |
Purified water, Hypromellose 2910, 15 mpa.s, Canagliflozin, Croscarmellose sodium, MICROCRYSTALLINE CELLULOSE |
Janssen-Cilag International NV |
— |
| Vokanamet 150 mg/850 mg Film-coated tablet EU/1/14/918/007-009 |
MICROCRYSTALLINE CELLULOSE, Croscarmellose sodium, Canagliflozin, Purified water, Metformin Hydrochloride |
Janssen-Cilag International NV |
— |
| Vokanamet 50 mg/1000 mg Film-coated tablet EU/1/14/918/004-006 |
Metformin Hydrochloride, MICROCRYSTALLINE CELLULOSE, Hypromellose 2910, 15 mpa.s, Purified water, Croscarmellose sodium |
Janssen-Cilag International NV |
— |
| Vokanamet 50 mg/850 mg Film-coated tablet EU/1/14/918/001-003 |
Metformin Hydrochloride, Purified water, Croscarmellose sodium, Hypromellose 2910, 15 mpa.s, MICROCRYSTALLINE CELLULOSE |
Janssen-Cilag International NV |
— |
| Volibris 10 mg film-coated tablets EU/1/08/451/003-004 |
Ambrisentan |
GlaxoSmithKline Trading Services Limited |
— |
| Volibris 2.5 mg film-coated tablet EU/1/08/451/005 |
Ambrisentan |
GlaxoSmithKline Trading Services Limited |
— |
| Volibris 5 mg film-coated tablets EU/1/08/451/001-002 |
Ambrisentan |
GlaxoSmithKline Trading Services Limited |
— |
| Voltfast Sachets 50mg Powder for Oral Solution PA2308/001/001 |
Diclofenac potassium |
Wisdom Pharmaceutical Technology Co Limited |
— |
| Voncento 1000 IU/2400 IU Powder and solvent for solution for injection/infusion EU/1/13/857/004 |
Von willebrand factor, Human coagulation factor viii |
CSL Behring GmbH |
— |